Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of trypanosome evangelica nanobody against vsg and its coding sequence and application

A nanobody, sequence technology, applied in the field of biotechnology or biomedicine

Active Publication Date: 2018-03-13
ZHEJIANG ACAD OF MEDICAL SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Belgian scientist Hamers.R first discovered in camel blood that ordinary antibody proteins consist of two heavy chains and two light chains, while the new antibodies found in camel blood have only two heavy chains and no light chains. Antibodies can tightly bind to antigens like normal antibodies, but they don't stick to each other like single-chain antibodies and aggregate into clumps

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of trypanosome evangelica nanobody against vsg and its coding sequence and application
  • A kind of trypanosome evangelica nanobody against vsg and its coding sequence and application
  • A kind of trypanosome evangelica nanobody against vsg and its coding sequence and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] This embodiment constructs the Trypanosoma evanii VSG specific nanobody library, the steps are as follows:

[0026] (1) Firstly, trypanosome evangelia VSG antigen was purified, then 1 mg of VSG antigen was mixed with Freund’s adjuvant in equal volume, and an alpaca (Alpa-Vet, www.alpa-vet.be) was immunized once a week for a total of Immunized 7 times to stimulate B cells to express antigen-specific nanobodies;

[0027] (2) After the 7 times of immunization, extract 100ml alpaca peripheral blood lymphocytes and extract total RNA;

[0028] (3) Synthesize cDNA and amplify VHH by nested PCR;

[0029] (4) Digest 20ug of phage display vector and 10ul of VHH with restriction enzymes pstI and NotI and connect the two fragments;

[0030] (5) Transform the ligation product into electroporation-competent cells TG1, construct the VSG nanobody library and measure the storage capacity, the storage capacity is 5.1×10 9 .

Embodiment 2

[0032] In this embodiment, VSG-specific nanobodies are screened, and the steps are as follows:

[0033] (1) Dissolve in 100mM NaHCO 3 20ug VSG at pH 8.2 was coated on the NUNC microtiter plate and placed overnight at 4°C;

[0034] (2) Add 100ul 3% milk the next day, and block at room temperature for 2 hours;

[0035] (3) After 2 hours, add 100ul 10 11 tfu contains the helper phage of the VSG nanobody library, and acts at room temperature for 1 hour;

[0036] (4) Wash 10 times with 0.05% PBS+Tween-20 for the first round of panning / 20-25 times for the second round / 20 times for the third round to remove non-specifically bound phages;

[0037] (5) Use 100mM TEA (triethylamine) to dissociate the phage that specifically binds to VSG, and infect Escherichia coli TG1 in logarithmic growth phase, culture at 37°C for 1 hour, produce and purify the phage for the next round of screening, the same The screening process was repeated for 3-4 rounds, and the enrichment was obtained step b...

Embodiment 3

[0039] In this example, phage enzyme-linked immunosorbent assay (ELISA) was used to screen specific single positive clones, and the steps were as follows:

[0040] (1) From the cell culture dish containing phage after the above 3-4 rounds of screening, select 96 single colonies and inoculate them in TB medium containing 100ug / ml ampicillin, grow to the logarithmic phase, and add the final concentration 1 mM IPTG, culture overnight at 28°C.

[0041] (2) Use the infiltration method to obtain the crudely extracted antibody, transfer the antibody to an antigen-coated ELISA plate, and place it at room temperature for 1 hour;

[0042] (3) Wash off unbound antibodies with PBST, add mouse anti-His antibody (mouse anti-HIS antibody, R&D system), and place at room temperature for 1 hour;

[0043] (4) Wash off the unbound antibody with PBST, and add anti-mouse alkaline phosphataseconjugate (goat anti-mouse AP labeled antibody, sigma).

[0044] (5) Wash off the unbound antibody with PBS...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nanobody against the epitope of the variant surface glycoprotein (VSG) of Trypanosoma evansi, and also discloses a gene sequence encoding the nanobody and a host cell expressing the nanobody. Through the nanobody gene sequence and host cell disclosed in the present invention, the nanobody can be highly expressed in Escherichia coli and applied to the research and development of trypanosome detection reagents.

Description

technical field [0001] The present invention relates to the field of biotechnology or biomedicine, and relates to a nanobody against trypanosoma evangelica variant surface glycoprotein (variant surface glucoprotein, VSG), its coding sequence and application. Background technique [0002] Trypanosoma evansi (Trypanosoma evansi) disease is a blood protozoan disease caused by Trypanosoma evansi, which is widely distributed in the world and distributed in many regions of my country. Trypanosomiasis mainly parasitizes domestic animals such as horses, donkeys, mules, buffaloes, cattle, dairy cows, and sheep. Some wild animals such as tigers, deer, and camels are also commonly infected. Trypanosomiasis can directly cause acute death or latent infection of animals, resulting in anemia, stillbirth, miscarriage, decreased lactation, etc., causing great losses to my country's animal husbandry. In addition, there are reports of human infection abroad, so trypanosomiasis is also a zoono...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/20C12N15/63C12N15/13G01N33/569
Inventor 陈睿马格斯斯蒂芬陆绍红童群波孔庆明郑斌楼涤丁建祖
Owner ZHEJIANG ACAD OF MEDICAL SCI